| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
34,730,000 |
| Market
Cap: |
477.54(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$13.75 - $13.75 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Vittiglio Joseph |
SVP, General Counsel |
• – – |
2017-08-29 |
4 |
AS |
$16.75 |
$20,938 |
D/D |
(1,250) |
33,504 |
|
- |
|
| Vittiglio Joseph |
SVP, General Counsel |
• – – |
2017-08-24 |
4 |
D |
$17.50 |
$28,578 |
D/D |
(1,633) |
34,754 |
|
- |
|
| Krop Julie |
SVP Clinical & Regulatory, CMO |
• – – |
2017-07-13 |
4 |
AS |
$20.00 |
$98,760 |
D/D |
(4,938) |
28,336 |
|
- |
|
| Krop Julie |
SVP Clinical & Regulatory, CMO |
• – – |
2017-06-01 |
4 |
D |
$17.90 |
$42,871 |
D/D |
(2,395) |
33,274 |
|
- |
|
| Russell Lesley |
Director |
– • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,545 |
21,335 |
|
- |
|
| Kelley Brian P |
Director |
– • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,545 |
5,571 |
|
- |
|
| Sulat James R |
Director |
– • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,545 |
13,127 |
|
- |
|
| Fallon John A. |
Director |
– • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,545 |
15,399 |
|
- |
|
| Deptula Barbara |
Director |
– • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,545 |
14,660 |
|
- |
|
| Santini Gino |
Director |
– • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,545 |
19,510 |
|
- |
|
| Perez Robert J |
Director |
– • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,545 |
17,535 |
|
- |
|
| Scoon Davey |
Director |
– • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,545 |
21,935 |
|
- |
|
| Vittiglio Joseph |
SVP, General Counsel |
• – – |
2017-05-08 |
4 |
D |
$18.55 |
$18,179 |
D/D |
(980) |
36,387 |
|
- |
|
| Heiden William K |
President & CEO |
• • – |
2017-05-08 |
4 |
D |
$18.55 |
$354,027 |
D/D |
(19,085) |
272,561 |
|
- |
|
| Myles Edward H |
Chief Financial Officer |
• – – |
2017-05-08 |
4 |
D |
$18.55 |
$40,383 |
D/D |
(2,177) |
32,823 |
|
- |
|
| Grund Nicholas |
Chief Commercial Officer |
• – – |
2017-05-08 |
4 |
D |
$18.55 |
$64,610 |
D/D |
(3,483) |
48,517 |
|
- |
|
| Krop Julie |
SVP Clinical & Regulatory, CMO |
• – – |
2017-05-01 |
4 |
AS |
$24.45 |
$46,235 |
D/D |
(1,891) |
36,777 |
|
- |
|
| Krop Julie |
SVP Clinical & Regulatory, CMO |
• – – |
2017-03-01 |
4 |
D |
$22.85 |
$25,318 |
D/D |
(1,108) |
35,669 |
|
- |
|
| Heiden William K |
CEO |
• • – |
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
85,000 |
291,646 |
|
- |
|
| Vittiglio Joseph |
SVP, General Counsel |
• – – |
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
37,367 |
|
- |
|
| Thomas Frank E |
President & COO |
• – – |
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
138,195 |
|
- |
|
| Myles Edward H |
Chief Financial Officer |
• – – |
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
35,000 |
|
- |
|
| Krop Julie |
SVP Clinical & Regulatory, CMO |
• – – |
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
38,668 |
|
- |
|
| Kelley Brian P |
Director |
– • – |
2016-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,026 |
1,026 |
|
- |
|
| Krop Julie |
SVP Clinical & Regulatory, CMO |
• – – |
2016-10-20 |
4 |
AS |
$24.80 |
$122,462 |
D/D |
(4,938) |
23,668 |
|
- |
|
627 Records found
|
|
Page 7 of 26 |
|
|
